Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ZOETIS INC
01/11 ZOETIS : Colleagues Make a Difference in Their Communities
01/03 ZOETIS : PHARMAQ Acquires Fish Vaccination Company Nordland Sett Vaks
2016 ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 201..
2016 ZOETIS : joins GlobalVetLINK’s VFD system
2016 ZOETIS INC. (NASDAQ : ZTS) Files An 8-K Entry into a Material Definitive Agreeme..
2016 ZOETIS INC. (NYSE : ZTS) Files An 8-K Entry into a Material Definitive Agreement
2016 ZOETIS : Receives USDA License for CYTOPOINT™
2016 ZOETIS : to Participate in the 35th Annual J.P. Morgan Healthcare Conference
2016 ZOETIS : Safe And Sound During The Holidays
2016 Zoetis Inc. , Workday, Inc., CenterPoint Energy, Inc.
2016 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
2016 ZOETIS : Announces Authorization of $1.5 Billion Share Repurchase Program
2016 MYTHS AND FACTS : is internal parasite control necessary?
2016 ZOETIS : FluSure XP vaccine with strain update now available from Zoetis
2016 ANATARA LIFESCIENCES LTD (ASX : ANR) Chairman's Address to Shareholders
More most relevant news
All news about ZOETIS INC
01/11 ZOETIS : Colleagues Make a Difference in Their Communities
01/03 ZOETIS : PHARMAQ Acquires Fish Vaccination Company Nordland Sett Vaks
2016 ZOETIS : FDA Issues Rule for Withdrawal of Approval of New Animal Drug Applicati..
2016 ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 201..
2016 ZOETIS : Receives USDA License for CYTOPOINT™
2016 ZOETIS : joins GlobalVetLINK’s VFD system
2016 ZOETIS INC. (NASDAQ : ZTS) Files An 8-K Entry into a Material Definitive Agreeme..
2016 ZOETIS INC. (NYSE : ZTS) Files An 8-K Entry into a Material Definitive Agreement
2016 ZOETIS INC. : Entry into a Material Definitive Agreement, Financial Statements a..
2016 ZOETIS : Receives USDA License for CYTOPOINT™
More news
Sector news : Veterinary Drugs
01/20 European shares ease ahead of Trump inauguration
01/20 Bristol-Myers shares fall on lung cancer timeline setback
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/19 GSK grabs Astra executive to replace pharma head
More sector news : Veterinary Drugs
News from SeekingAlpha
01/18 Vet med industry now dominated by four firms; further mergers unlikely
01/18 Zoetis goes ex-dividend today
01/12 Stocks Going Ex-Dividend The Third Week Of January
01/12 Zoetis (ZTS) Presents At 35th Annual J.P. Morgan Healthcare Conference "
01/09 Mars deal throws a spotlight on the pet care sector
2016 Dividend Champions For January 2017
Latest Tweets
01/20$ZTS .. JAN WEEKLY 53.5 CALL Activity 900+ @$1.20 on OFFER .. Expire Jan 27 
01/20Zoetis's PT raised by Jefferies Group to $64.00.  
01/19Wall Street's M&A Chatter From January 18  
01/18Vet med industry now dominated by four firms; further mergers unlikely  
01/18$ZTS this moving the stock. Possible German co looking at them...
2
More tweets
Qtime:100
Advertisement
Financials ($)
Sales 2016 4 886 M
EBIT 2016 1 565 M
Net income 2016 899 M
Debt 2016 2 719 M
Yield 2016 0,72%
P/E ratio 2016 30,72
P/E ratio 2017 24,90
EV / Sales 2016 6,01x
EV / Sales 2017 5,44x
Capitalization 26 652 M
More Financials
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 57,5 $
Spread / Average Target 6,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC0.82%26 420
JINYU BIO-TECHNOLOGY C..49.34%2 712
DECHRA PHARMACEUTICALS..5.72%1 653
VIRBAC0.90%1 523
SHANGHAI HILE BIO TECH..-10.66%1 501
PULIKE BIOLOGICAL ENGI..-3.27%1 092
More Results